[1]
Prasasty, V.D. and Yulandi, A. 2015. STRUCTURE-BASED DESIGN OF NOVEL RILPIVIRINE ANALOGUES AS HIV-1 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THROUGH QSPR AND MOLECULAR DOCKING. International Journal of Pharmacy and Pharmaceutical Sciences. 7, 11 (Nov. 2015), 340–345.